if yes ,then be a responsible patients and start reporting
- what to report ?
you can report all type of side effect /adverse drugs reaction caused by medicine whether known and unknown ,serious or non-serious to Pharmacovigilance
pogramme of India (PvPI)
HOW AND WHERE TO REPORT you can use any of these tools to report
NEAREST MONITORING CENTRE
- List is available on :www.ipc.gov.in
ADR REPORTIN FORM
- Available on :www.ipc. gov
ADR PvPI MOBLIE APPLICATION
- Available on : google play store
ADR REPORTING FORM
- Available on http://www.ipc.gov.in/
MONDAY TO FRIDAY 9:00AM TO 5:30PM.
HELPLINE TOLL FREE NO. 1800 180 3024.
The Pharmacovigilance Programme of India (PvPI) is a national program for the monitoring and assessment of adverse drug reactions (ADRs) in India. It was established in 2010 by the Indian Pharmacopoeia Commission (IPC) under the Ministry of Health and Family Welfare, Government of India.
The Indian Pharmacopoeia Commission (IPC) is a scientific body established by the Government of India in 1963 under the Ministry of Health and Family Welfare. The IPC is responsible for the publication of the Indian Pharmacopoeia (IP), which is the official compendium of standards for drugs and pharmaceuticals in India. The IP contains information on the identity, purity, assay, and other quality standards for drugs and pharmaceuticals. The IPC also sets standards for packaging, labeling, and storage of drugs and pharmaceuticals.
The IPC is headed by a Chairperson, who is a renowned pharmacologist or pharmaceutical scientist. The IPC has a number of subcommittees, each of which is responsible for a specific aspect of the pharmacopoeia, such as monographs, analytical methods, and quality control. The IPC also has a number of expert committees, which provide advice to the IPC on various technical matters.
The IPC is a member of the World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations. The IPC also collaborates with other national pharmacopoeias, such as the United States Pharmacopoeia and the British Pharmacopoeia.
The IPC plays an important role in ensuring the quality and safety of drugs and pharmaceuticals in India. The IP is used by drug manufacturers, quality control laboratories, and regulatory authorities to ensure that drugs and pharmaceuticals meet the required standards. The IPC also provides training and education on the IP to various stakeholders.
Here are some of the key functions of the IPC:
- To publish the Indian Pharmacopoeia (IP), which is the official compendium of standards for drugs and pharmaceuticals in India.
- To set standards for packaging, labeling, and storage of drugs and pharmaceuticals.
- To provide advice to the Government of India on matters related to the quality of drugs and pharmaceuticals.
- To collaborate with other national pharmacopoeias and the WHO on matters related to the quality of drugs and pharmaceuticals.
The IPC is a key institution in India’s efforts to ensure the quality and safety of drugs and pharmaceuticals. The IPC’s work plays an important role in protecting the health of the Indian public.
The Pharmacovigilance Programme of India (PvPI) is a national program for the monitoring and assessment of adverse drug reactions (ADRs) in India. It was established in 2010 by the Indian Pharmacopoeia Commission (IPC) under the Ministry of Health and Family Welfare, Government of India.
The PvPI is a collaborative program involving various stakeholders, including drug manufacturers, healthcare professionals, patients, and consumers. The program aims to collect and analyze data on ADRs in India, identify risk factors, and develop preventive measures.
The PvPI has a number of components, including:
- ADR reporting: The PvPI has a national ADR reporting system, which allows healthcare professionals and patients to report ADRs online or by phone.
- ADR monitoring: The PvPI monitors ADRs reported through the national ADR reporting system, as well as other sources, such as medical journals and regulatory databases.
- ADR assessment: The PvPI assesses the causality of ADRs and identifies risk factors.
- ADR prevention: The PvPI develops and implements preventive measures to reduce the occurrence of ADRs.
The PvPI has played a significant role in improving the safety of drugs and pharmaceuticals in India. The program has helped to identify a number of serious ADRs, which have led to the withdrawal or modification of drugs from the market. The PvPI has also helped to raise awareness of ADRs among healthcare professionals and patients.
Here are some of the benefits of the PvPI:
- Improved safety of drugs and pharmaceuticals in India
- Identification of serious ADRs, which has led to the withdrawal or modification of drugs from the market
- Raised awareness of ADRs among healthcare professionals and patients
- Improved communication between healthcare professionals and patients about ADRs
- Enhanced capacity of the Indian regulatory system to monitor and manage ADRs
The PvPI is an important initiative of the Government of India to ensure the safety of drugs and pharmaceuticals in the country. The program has made significant progress in its short history, and it is expected to continue to play a vital role in improving the safety of drugs and pharmaceuticals in India in the years to come.
